(Q24240411)

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Physical examination. Its role as a single screening modality in the Canadian National Breast Screening Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Canadian National Breast Screening Study: assessment of technical quality by external review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Sensitivity and specificity of first screen mammography in the Canadian National Breast Screening Study: a preliminary report from five centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Changes in breast self-examination behavior achieved by 89,835 participants in the Canadian National Breast Screening Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Women's attitudes to screening after participation in the National Breast Screening Study. A questionnaire survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Relationship Between Mammographic and Histological Risk Factors for Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

A critical appraisal of the Canadian National Breast Cancer Screening Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

The Canadian National Breast Screening Study: a Canadian critique

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Using an alternative data source to examine randomization in the Canadian National Breast Screening Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Assessing the extent of contamination in the Canadian National Breast Screening Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Body mass index and mortality in women: follow-up of the Canadian National Breast Screening Study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

The Canadian National Breast Screening Study: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Mammography screening for breast cancer. Reply to the commentaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Statistical power in breast cancer screening trials and mortality reduction among women 40-49 years of age with particular emphasis on the National Breast Screening Study of Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

On being the right size: a reappraisal of mammography trials in Canada and Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Randomisation by cluster and the problem of social class bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Edinburgh trial of screening for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Use of risk factors to allocate schedules for breast cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Comparative pathology of breast cancer in a randomised trial of screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

The efficacy of surgical treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Psychiatric morbidity after screening for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

The Edinburgh randomised trial of screening for breast cancer: description of method

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

The Gothenburg Breast Screening Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Long-term effects of mammography screening: updated overview of the Swedish randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Breast cancer screening with mammography: overview of Swedish randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Detection method, tumour size and node metastases in breast cancers diagnosed during a trial of breast cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Breast cancer screening with mammography: a population-based, randomized trial with mammography as the only screening mode

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Interval carcinomas in the Malmö Mammographic Screening Trial: radiographic appearance and prognostic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

The case-control design and the assessment of the efficacy of cancer screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

The reluctant participant in a breast cancer screening program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Impact of efforts to increase participation in repetitive screenings for early breast cancer detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

An analysis of survival differences between clinically and screen-detected cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Evidence on screening for breast cancer from a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

The status of breast cancer screening: a quarter of a century of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Evaluation of periodic breast cancer screening with mammography: methodology and early observations. 1966.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

The search for risk factors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Breast cancer found on repetitive examination in mass screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

The Stockholm breast cancer screening trial--5-year results and stage at discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Analysis of interval breast carcinomas in a randomized screening trial in Stockholm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Interval cancer and survival in a randomized breast cancer screening trial in Stockholm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Nonattendance in the Stockholm mammography screening trial: Relative Mortality and reasons for nonattendance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Breast cancer screening programmes: the development of a monitoring and evaluation system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Cluster randomization in large public health trials: the importance of antecedent data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Breast screening, prognostic factors and survival – results from the Swedish two county study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Survival in breast cancer diagnosed between mammographic screening examinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Criticisms of Swedish mammography trials were wrong

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Screening with mammography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Randomised controlled trial of mammographic screening in women from age 40: results of screening in the first 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Randomised controlled trial of mammographic screening in women from age 40: predicted mortality based on surrogate outcome measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Follow-up of two treatment modalities for ductal cancer in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Influence of S-phase fraction on metastatic pattern and post-recurrence survival in a randomized mammography screening trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Cytometric and histopathologic features of tumors detected in a randomized mammography screening program: correlation and relative prognostic influence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Invasive interval cancers in the Ostergötland Mammographic Screening Programme: radiological analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Long-term outcome of the Malmö preventive project: mortality and cardiovascular morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Evaluating periodic multiphasic health checkups: A controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

The Canadian National Breast Screening Study: a perspective on criticisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Perceived sensitivity of mammographic screening: women's views on test accuracy and financial compensation for missed cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Model of outcomes of screening mammography: information to support informed choices

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Increased patient concern after false-positive mammograms: clinician documentation and subsequent ambulatory visits

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Benefits and risks of screening mammography for women in their forties: a statistical appraisal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

ABC of breast diseases: screening for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Global summit on mammographic screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Systematic review: the long-term effects of false-positive mammograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Validation of a condition-specific measure for women having an abnormal screening mammography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Noncancer deaths in white adult cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Women’s perception of the benefits of mammography screening: population-based survey in four countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

The mammographic screening trials: commentary on the recent work by Olsen and Gøtzsche.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Ten-year risk of false positive screening mammograms and clinical breast examinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Effects of repeated mammographic screening on breast cancer stage distribution. Results from a randomised study of 92 934 women in a Swedish county.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Report of the International Workshop on Screening for Breast Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Clinical practice. Mammographic screening for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

On the diagnosis and treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

On the efficacy of screening for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Meta-analysis adjusting for compliance: the example of screening for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Quality of life following a false positive mammogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Breast screening programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Is screening for breast cancer with mammography justifiable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

On the benefits and harms of screening for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Content of invitations for publicly funded screening mammography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Regular self-examination or clinical examination for early detection of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Psychological and behavioral implications of abnormal mammograms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Neglected aspects of false positive findings of mammography in breast cancer screening: analysis of false positive cases from the Stockholm trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Validity of cancer registry data for measuring the quality of breast cancer care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Interventions for relieving the pain and discomfort of screening mammography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

"Benign" tumors and "early detection" in mammography-screened patients of a natural cohort with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Breast cancer incidence after the start of mammography screening in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Are breast cancer screening programmes increasing rates of mastectomy? Observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Edinburgh trial of screening for breast cancer: mortality at seven years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Enthusiasm for cancer screening in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

How risks of breast cancer and benefits of screening are communicated to women: analysis of 58 pamphlets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Comparison of screening mammography in the United States and the United kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Value of mammography in reduction of mortality from breast cancer in mass screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Update on effects of screening mammography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Mammographic screening: a key factor in the control of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

The voice of the breast cancer patient--a lonely cry in the wilderness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Meta-analysis of screening data: a survey of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Cochrane review on screening for breast cancer with mammography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

Evaluation of periodic breast cancer screening with mammography. Methodology and early observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Evaluation of Periodic Breast Cancer Screening With Mammography

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Periodic Breast Cancer Screening in Reducing Mortality From Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Mammography and clinical examination in mass screening for cancer of the breast

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Mass screening in mammary cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Mass screening for control of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Changes in breast self-examination behavior in a cohort of 8214 women in the Canadian National Breast Screening Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Determining the efficacy of breast cancer screening

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Cytometric characterization and clinical course of breast cancer diagnosed in a population-based screening program

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

New Swedish breast cancer detection results for women aged 40-49

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Breast screening and surgical problems

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Benign breast disease and cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Additional value of fine-needle aspiration biopsy in a mammographic screening trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Time-dependent effects on survival in breast carcinoma: results of 20 years of follow-up from the Swedish Two-County Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Screening: assessment of current studies.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Highlights of the evidence of benefit for women aged 40-49 years from the 14-year follow-up of the Breast Cancer Detection Demonstration Project.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Tumour development, histology and grade of breast cancers: Prognosis and progression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Breast-cancer screening with mammography in women aged 40-49 years. Swedish Cancer Society and the Swedish National Board of Health and Welfare

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Five-Year Experience with Single-View Mammography Randomized Controlled Screening in Sweden

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Breast Cancer Screening in Malmö

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Experience from Randomized Controlled Breast Screening with Mammography in Östergötland County, Sweden: A Preliminary Report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Screening for breast cancer in Malmö: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Diagnostic outcome of repeated mammography screening

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Randomized mammographic screening for breast cancer in Stockholm. Design, first round results and comparisons

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Randomized study of mammography screening — preliminary report on mortality in the stockholm trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Mammography in mass screening

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Evaluation of two contrasting types of screening programs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Screening mammography

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Breast cancer treatment and natural history: new insights from results of screening

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Breast cancer screening with mammography

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Screening mammography

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Impediments to recruitment in the Canadian National Breast Screening Study: response and resolution

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Mammographic breast cancer screening--a randomized trial in Malmö, Sweden

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Screening mammography re-evaluated

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Screening for breast cancer with mammography

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Screening for breast cancer with mammography

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Update on effects of screening mammography

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Canadian National Breast Screening Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Comparative pathology of prevalent and incident cancers detected by breast screening. Edinburgh Breast Screening Project

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Screening for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Significance of increased efforts to gain participation in screening for breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Empirical comparison of the results of randomized controlled trials and case-control studies in evaluating the effectiveness of screening mammography

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Trends in breast-conserving surgery in the Southeast Netherlands: comments on article by Ernst and colleagues. Eur J Cancer 2001, 37, 2435-2440

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

The Canadian National Breast Screening Study: responses to controversy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Followup after 11 years--update of mortality results in the Stockholm mammographic screening trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Update of the Swedish Two-County Trial of breast cancer screening: histologic grade-specific and age-specific results

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Trial of early detection of breast cancer: description of method

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

An analysis of the mortality effect in a breast cancer screening study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Sojourn Time, Sensitivity and Positive Predictive Value of Mammography Screening for Breast Cancer in Women Aged 40-49

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Primary and adjuvant therapy, prognostic factors and survival in 1053 breast cancers diagnosed in a trial of mammography screening

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Analysis of Breast Cancer Mortality and Stage Distribution by Age for the Health Insurance Plan Clinical Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Re: "Author of Canadian breast cancer study retracts warnings"

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Re: May we agree to disagree, or how do we develop guidelines for breast cancer screening in women?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Re: Quantitative interpretation of age-specific mortality reductions from the Swedish Breast Cancer-Screening Trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Mammographic densities and risk of breast cancer among subjects with a family history of this disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Mammography versus clinical examination of the breasts

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Periodic screening for breast cancer: the HIP Randomized Controlled Trial. Health Insurance Plan

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

The Edinburgh Randomized Trial of Breast Cancer Screening.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

The Canadian National Breast Screening Study: update on breast cancer mortality.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Recent results from the Swedish Two-County Trial: the effects of age, histologic type, and mode of detection on the efficacy of breast cancer screening

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

The Stockholm Mammographic Screening Trial: Risks and benefits in age group 40-49 years

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

The Gothenburg Breast Cancer Screening Trial: preliminary results on breast cancer mortality for women aged 39-49

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Updated overview of the Swedish Randomized Trials on Breast Cancer Screening with Mammography: age group 40-49 at randomization

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Reduced breast cancer mortality in women under age 50: updated results from the Malmö Mammographic Screening Program

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Variation in the effectiveness of breast screening by year of follow-up

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

The quality and interpretation of mammographic screening trials for women ages 40-49

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Markov models of breast tumor progression: some age-specific results

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Lead time in breast cancer detection and implications for periodicity of screening.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Epidemiologic determinants of the mammographic parenchymal pattern. A population-based study within a mammographic screening program

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Analysis of the temporal patterns of benefits in the Health Insurance Plan of Greater New York trial by stage and age

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Case-control evaluation of breast cancer screening efficacy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

The role of the reference radiologist. Estimates of inter-observer agreement and potential delay in cancer detection in the national breast screening study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Screening for breast cancer. Report from Edinburgh Breast Screening Clinic

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Demands on surgical inpatient services after mass mammographic screening

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Association between mortality among women and socioeconomic factors in general practices in Edinburgh: an application of small area statistics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Breast screening: the facts--or maybe not

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Screening for breast cancer: the Swedish trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Radiographic patterns of the mammary parenchyma: variation with age at examination and age at first birth

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Radiographic screening for breast carcinoma. I. Program and primary findings in 45--69 year old women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Radiographic screening for breast carcinoma. III. Appearance of carcinoma and number of projections to be used at screening

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Radiographic screening for breast carcinoma. II. Prognostic considerations on the basis of a short-term follow-up

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Effect of breast cancer screening after age 65

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Screening for breast cancer in women aged under 50: mode of detection, incidence, fatality, and histology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

An overview of the Swedish randomised mammography trials: total mortality pattern and the representivity of the study cohorts

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

The Swedish randomised mammography screening trials: analysis of their effect on the breast cancer related excess mortality

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Screening status in relation to biological and chronological characteristics of breast cancers: a cross sectional survey

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Number needed to screen: lives saved over 20 years of follow-up in mammographic screening

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Prospects for eliminating racial differences in breast cancer survival rates

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Canadian National Breast Screening Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Non-palpable invasive breast carcinomas from the Stockholm screening project

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021

Histopathologic and cytochemical characteristics of interval breast carcinomas from the Stockholm Mammography Screening Project

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001877.PUB3

7 January 2021